Molecular regulation of angioblast migration during cornea development
角膜发育过程中成血管细胞迁移的分子调控
基本信息
- 批准号:8222363
- 负责人:
- 金额:$ 37.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdultAngioblastAngiogenic FactorBehaviorBindingBiological AssayBirdsBlindnessBlood VesselsCXC ChemokinesCardiacCellsChemotactic FactorsComplicationContact LensesCorneaCoupledDefectDevelopmentDiseaseEmbryoEndothelial CellsEndotheliumEquilibriumEyeEye DevelopmentFibroblast Growth FactorGenesGeneticImmigrationImmunohistochemistryIn Situ HybridizationIn VitroInfectionKnockout MiceLigandsMaintenanceMalignant NeoplasmsMigration AssayMitogensMolecularMusMutant Strains MiceNeural CrestNeural Crest CellOphthalmologyPatternPeptidesPlayQuailRNA InterferenceRegulationRoleSignal TransductionTestingTherapeuticTimeTissuesTransgenic OrganismsTraumaVascular Endothelial Growth FactorsVascularizationVisionVisual AcuityWorkangiogenesisantiangiogenesis therapybasecytokineembryo tissuegain of functionin vivoinsightlensloss of functionmigrationmutantneovascularneovascularizationoverexpressionprecursor cellreceptorresearch studyspatiotemporaltumortumor growthvasculogenesis
项目摘要
DESCRIPTION (provided by applicant): Vascularization of the cornea is a vision-threatening complication. The molecular mechanisms underlying corneal avascularity are still not well understood and comparatively little is known about the development of corneal avascularity. We propose to study the molecular regulation of migratory blood vessel precursor cells (angioblasts) during development of corneal avascularity. Previously, we showed that periocular angioblasts express Neuropilin1 (Nrp1) a dual receptor for the angiogenic vascular endothelial growth factor (VEGF) and the anti-angiogenic guidance molecule Semaphorin3A (Sema3A). Our ongoing studies show that periocular angioblasts also express PlexinD1 a receptor for anti-angiogenic Sema3E during cornea development. We also show that the anti-angiogenic cytokine CXCL14 is strongly expressed by stromal keratocytes shortly after differentiation. Based on these observations we hypothesize that a tightly regulated balance between pro- and anti-angiogenic factors controls angioblast migration and vascular patterning during development of corneal avascularity. To test this hypothesis, we will take advantage of mouse genetics and the ease of manipulating avian eyes to explore the function of inhibitory genes associated with vasculogenesis during corneal development. We will examine the behavior of migratory angioblasts during eye development to determine where and when they segregate from other migratory cells that give rise to the cornea stroma and endothelium. We will determine the spatiotemporal expression of guidance genes and their receptors during cornea development by qPCR, in situ hybridization, and immunohistochemistry. We will perform loss- and gain-of-function experiments in Tie1:H2B-eYFP transgenic quail embryos with fluorescent blood vessels to elucidate the function of inhibitory molecules and their receptors during periocular angioblast migration. Knockout mice lacking the function of each inhibitory gene or receptor will be examined in detail for defects in angioblast migration and vascularization of the cornea. In vivo experiments will be coupled with in vitro migration assays to directly test the effect of inhibitory molecules on periocular angioblast migration in isolation from other ocular tissues. The following Specific Aims will test our hypothesis: 1. Determine the role of Nrp1 and its ligands VEGF and Sema3A in angioblast migration during development of corneal avascularity. 2. Identify the role of PlexinD1 during development of corneal avascularity. 3. Determine the functional significance of CXCL14 expression during cornea development. Successful completion of our proposed study will provide insight into the mechanisms that regulate angioblast migration and vasculogenesis leading to development of an avascular cornea. Similar mechanisms may inhibit neovascularization of the normal adult cornea and thus pave the way for discovery of potential therapeutic anti-angiogenesis agents for treating vascularized adult corneas and targeting angiogenesis due to cancer.
PUBLIC HEALTH RELEVANCE: The transparent cornea is a highly innervated but remains avascular. Inappropriate vascularization of the cornea can result in loss of visual acuity or blindness. Angioblasts and endothelial cells express receptors for attractive and repulsive signals that guide their migration and vascularization of specific embryonic tissues. Angioblasts express receptors for several inhibitory molecules at a critical time as they migrate adjacent to the developing cornea. We propose to determine the role of inhibitory guidance molecules during the selective avoidance of migratory periocular angioblasts but not neural crest cells of the developing cornea, which results in its avascularity.
描述(由申请人提供):角膜血管化是一种威胁视力的并发症。角膜无血供的分子机制目前还不清楚,对角膜无血供的发展也知之甚少。我们建议研究角膜无血管形成过程中迁移性血管前体细胞(成血管细胞)的分子调控。以前,我们发现眼周成血管细胞表达神经纤毛蛋白1(Nrp 1),一种血管生成血管内皮生长因子(VEGF)和抗血管生成导向分子Semaphorin 3A(Sema 3A)的双重受体。我们正在进行的研究表明,眼周成血管细胞在角膜发育过程中也表达抗血管生成Sema 3E的受体PlexinD 1。我们还表明,抗血管生成细胞因子CXCL 14强烈表达的基质角膜细胞分化后不久。基于这些观察结果,我们推测,在角膜无血管性的发展过程中,促血管生成因子和抗血管生成因子之间的严格调节平衡控制着成血管细胞的迁移和血管图案化。为了验证这一假设,我们将利用小鼠遗传学和易于操纵的鸟类眼睛来探索角膜发育过程中与血管发生相关的抑制基因的功能。我们将研究眼发育过程中迁移性成血管细胞的行为,以确定它们在何处以及何时与其他迁移性细胞分离,从而产生角膜基质和内皮。我们将通过qPCR、原位杂交和免疫组织化学来确定角膜发育过程中引导基因及其受体的时空表达。我们将在具有荧光血管的Tie 1:H2 B-eYFP转基因鹌鹑胚胎中进行功能丧失和获得实验,以阐明眼周成血管细胞迁移过程中抑制分子及其受体的功能。将详细检查缺乏每种抑制基因或受体功能的敲除小鼠的角膜成血管细胞迁移和血管形成缺陷。体内实验将与体外迁移测定相结合,以直接测试抑制分子对与其他眼组织分离的眼周成血管细胞迁移的影响。以下具体目标将检验我们的假设:1。确定Nrp 1及其配体VEGF和Sema 3A在角膜无血管形成过程中成血管细胞迁移中的作用。2.确定丛蛋白D1在角膜无血管形成过程中的作用。3.确定角膜发育过程中CXCL 14表达的功能意义。成功完成本研究将有助于深入了解成血管细胞迁移和血管生成的调控机制,从而导致无血管角膜的形成。类似的机制可以抑制正常成人角膜的新血管形成,从而为发现用于治疗血管化成人角膜和靶向癌症引起的血管生成的潜在治疗性抗血管生成剂铺平道路。
公共卫生相关性:透明角膜是高度神经支配的,但仍然是无血管的。角膜血管形成不当可导致视力丧失或失明。成血管细胞和内皮细胞表达吸引和排斥信号的受体,这些信号指导它们的迁移和特定胚胎组织的血管化。当成血管细胞迁移到发育中的角膜附近时,它们在关键时刻表达几种抑制分子的受体。我们建议,以确定在选择性避免迁移眼周成血管细胞,但不是神经嵴细胞的发展中的角膜,这导致其avascularity抑制性指导分子的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Y Lwigale其他文献
Peter Y Lwigale的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Y Lwigale', 18)}}的其他基金
2022 Cornea and Ocular Surface Biology, Pathology and Regeneration GRC/GRS
2022 角膜和眼表面生物学、病理学和再生 GRC/GRS
- 批准号:
10377627 - 财政年份:2022
- 资助金额:
$ 37.07万 - 项目类别:
Function of Nephronectin in the corneal ECM during development, homeostasis, and wound healing
肾连蛋白在角膜 ECM 中的发育、稳态和伤口愈合过程中的功能
- 批准号:
10615668 - 财政年份:2020
- 资助金额:
$ 37.07万 - 项目类别:
Function of Nephronectin in the corneal ECM during development, homeostasis, and wound healing
肾连蛋白在角膜 ECM 中的发育、稳态和伤口愈合过程中的功能
- 批准号:
10393587 - 财政年份:2020
- 资助金额:
$ 37.07万 - 项目类别:
Analysis of genes involved in neural crest cell fate decisions during corneal development.
分析角膜发育过程中参与神经嵴细胞命运决定的基因。
- 批准号:
9312833 - 财政年份:2016
- 资助金额:
$ 37.07万 - 项目类别:
Analysis of genes involved in neural crest cell fate decisions during corneal development.
分析角膜发育过程中参与神经嵴细胞命运决定的基因。
- 批准号:
9166279 - 财政年份:2016
- 资助金额:
$ 37.07万 - 项目类别:
Molecular regulation of angioblast migration during cornea development
角膜发育过程中成血管细胞迁移的分子调控
- 批准号:
8424240 - 财政年份:2012
- 资助金额:
$ 37.07万 - 项目类别:
Molecular regulation of angioblast migration during cornea development
角膜发育过程中成血管细胞迁移的分子调控
- 批准号:
8618905 - 财政年份:2012
- 资助金额:
$ 37.07万 - 项目类别:
Role of Chemorepellants during Neural Crest Migration in the Eye
化学排斥剂在眼部神经嵴迁移过程中的作用
- 批准号:
7319677 - 财政年份:2007
- 资助金额:
$ 37.07万 - 项目类别:
Role of Chemorepellants during Neural Crest Migration in the Eye
化学排斥剂在眼部神经嵴迁移过程中的作用
- 批准号:
8073983 - 财政年份:2007
- 资助金额:
$ 37.07万 - 项目类别:
Role of Chemorepellants during Neural Crest Migration in the Eye
化学排斥剂在眼部神经嵴迁移过程中的作用
- 批准号:
7492065 - 财政年份:2007
- 资助金额:
$ 37.07万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.07万 - 项目类别:
Research Grant